High-resolution carotid MRI allows visualization of carotid atherosclerotic plaque characteristics. MRI serves as a noninvasive option for the detection of active plaque inflammation and intraplaque hemorrhage. Significant gains in signal-tonoise ratio and contrast-to-noise ratio can be obtained for carotid atheroma imaging at 3T compared with 1.5T. Normalized wall index or wall area on MRI has shown its efficacy in monitoring the response after medical therapy. T(2)* quantification in carotid plaques before and after the administration of ultrasmall superparamagnetic iron oxide particles shows difference in response to treatment according to drug doses. In conclusion, high-resolution MRI is useful in the diagnosis and monitoring of carotid atherosclerotic plaques prone to transient ischemic attack and stroke.
MRI capabilities in plaque characterization
MRI has been shown to accurately identify the fibrous cap, lipid-rich necrotic core, intraplaque hemorrhage, neovasculature and vascular wall inflammation ( Figs. 1-3 ). MRI is a histologically validated technique for prospective testing of the vulnerable plaque hypothesis (2) . High signal intensity (SI) in the plaque may suggest a focal area of fresh hemorrhage on time-of-flight (TOF) images (3) . New contrast agents and targeted molecular imaging open a window for MRI detection of thrombus and assessment of atherosclerotic activity and plaque vulnerability.
MRI techniques
Significant gains in signal-to-noise ratio (SNR) can be obtained for carotid atheroma imaging at 3T compared with 1.5T. There was also a trend towards increased contrast-to-noise ratio (CNR) (4). Excellent agreement was seen between contrast-enhanced MR angiography and T2-weighted SPACE sequence (dark blood-MRI using a 3-dimensional turbo spin echo with variable flip angles sequence) and between observers for assessment of lumen diameter, lumen area, vessel wall area, and degree of North American Symptomatic Carotid Endarterectomy Trial (NASCET) stenosis (r > 0.80, p < 0.001) (5) .
Carotid intima-media thickness (IMT) is not adequately reproducible when tracking the progression of carotid atherosclerosis. The variability of ultrasound measurements of carotid IMT are likely to be reduced by further development of automatic calculation of this index by magnetic resonance imaging (6) . Vessel wall imaging could quantify atherosclerotic plaque measurements more reliably with an improved blood suppression technique (7) . Accurate co-registration between ultrasonography and other modalities is feasible with a global positioning system (GPS)-like technology, which has significant clinical and research applicability (8) . The advantage of MRI over ultrasound is that the measurement variability is smaller, enabling smaller sample sizes and potentially shorter study duration in cardiovascular prevention trials (9) .
Horie et al. (10) investigated whether a difference in dynamic enhancement pattern in plaque components could be useful to assess plaque stability with multidetector CT angiography. With MRI, a higher HU was negatively correlated with signal intensity on T1-weighted imaging (r = -0.56, p<0.0001). Histology confirmed that HU was positively correlated with fibrous tissue (r = 0.67, p=0.001) and negatively correlated with a lipid-rich necrotic core with hemorrhage (r = -0.70, p<0.001). Moreover, less neovascularization and inflammation was found in plaques with a higher HU. Delayed-phase images of dynamic CT provide information regarding the dynamic change in contrast media from the early arterial phase. An increase in attenuation (HU) from the early phase on multidetector CT angiography indicates plaque stability with more fibrous tissue and a less lipid-rich necrotic core, intraplaque hemorrhage, and neovascularization. According to Tartari et al. (11) , ongoing contrast-enhanced (CE)-MR angiography with a neurovascular coil for the simultaneous detection of unstable plaques is feasible. Plaque assessment was performed starting with a diffusionweighted sequence and followed by a fat-suppressed T1-weighted sequence; after contrast-enhanced MR angiography (CE-MRA), all patients were evaluated with a T1-weighted 3-dimensional high-resolution sequence.
Kwee et al. (12) (qT(2)*) measurements provide an alternative method of quantifying USPIO uptake. These results also demonstrate that changes in USPIO uptake can be measured using post-USPIO imaging only.
Clinical evidences
According to Virani et al. (14) , extent of carotid atherosclerosis was associated with atherogenic cholesterol and lipoproteins in 1670 participants of Atherosclerosis Risk in Communities study. Atherogenic/anti-atherogenic cholesterol or particle ratios were associated with presence of a detectable lipid-rich core.
In a study of patients with atherosclerotic disease with 4 years of follow-up, only severe or bilateral carotid stenosis, and not moderate carotid stenosis and increased carotid intima-media thickness, were associated with progression of brain atrophy (15) were independently associated with a worse (intact thin or ruptured) stage of fibrous cap status. Patients with carotid artery lesions and intraplaque hemorrhage tend to be at higher risk of a subsequent ipsilateral ischemic event. Risk evaluation of carotid artery disease should include plaque characteristics (17) . Intraplaque hemorrhage evaluated by MRI identified neurologically unstable patients with increased levels of high-sensitivity C-reactive protein regardless of the degree of carotid stenosis (18). 
Therapy monitoring
Carotid MRI helps improve risk stratification for stroke in patients and monitor the response to medical therapies; assessing efficacy of medical treatment at individual and population levels. Using ultrasound, computed tomography or MRI, plaques may be measured to monitor regression and progression of plaque volumes or plaque components (Fig. 4) . Contrast-enhanced ultrasound, dynamic contrastenhanced MRI, and FDG-PET are being explored to target plaque inflammation and neovascularization. Noninvasive imaging and other advances in risk stratification aim to improve and individualize the management of patients with carotid atherosclerosis (20) . Saam et al. (21) found that increased normalized wall index on MRI and the use of statin therapy are associated with reduced rates of plaque progression amongst individuals with advanced, asymptomatic carotid atherosclerosis. According to Lee et al., nicotinic acid (high dose, 2 g) significantly reduced carotid wall area on MRI compared with placebo (adjusted treatment difference: -1.64 mm 2 [95% confidence interval: -3.12 to -0.16]; p = 0.03) (22) .
In conclusion, high-resolution MRI enables visualization of carotid atherosclerotic plaque characteristics prone to transient ischemic attack and stroke. Carotid MRI allows quantification of plaque volumes and plaque components and thereby monitoring of response to therapy.
